Neuropsychological effects of epilepsy and antiepileptic drugs

Epilepsy and its treatment can have deleterious cognitive and behavioural consequences. Affected individuals have a higher prevalence of neuropsychological dysfunction than the general population because of complex interactions among several multifaceted and overlapping influences--for example, underlying neuropathologies, ictal and interictal neuronal discharges, a plethora of antiepileptic drugs, and numerous psychosocial issues. Research into the clinical relevance of these factors has been dogged by a range of methodological pitfalls including lack of standardisation of neuropsychological tests, small numbers and multiple testing, and statistical failure to appreciate differential effects of interactive elements in individual patients. Although antiepileptic drugs can impair neuropsychological functioning, their positive effect on seizure control might improve cognition and behaviour. Each person should be assessed individually with respect to factors unique to his or her seizure disorder and its treatment.

[1]  G. Pledger,et al.  A Multicenter, Randomized Clinical Study to Evaluate the Effect on Cognitive Function of Topiramate Compared with Valproate as Add‐On Therapy to Carbamazepine in Patients with Partial‐Onset Seizures , 2000, Epilepsia.

[2]  A. Aldenkamp,et al.  Cognitive effects of a new pyrrolidine derivative (levetiracetam) in patients with epilepsy , 1995, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[3]  M. Trimble,et al.  Vigabatrin and psychosis. , 1991, Journal of neurology, neurosurgery, and psychiatry.

[4]  C. Dodrill,et al.  Effects of Differing Dosages of Vigabatrin (Sabril) on Cognitive Abilities and Quality of Life in Epilepsy , 1995, Epilepsia.

[5]  D. Andrewes,et al.  Degree of left hippocampal atrophy correlates with severity of neuropsychological deficits , 1997, Seizure.

[6]  M. Brodie,et al.  A double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy with health-related quality of life as an outcome measure , 2000, Seizure.

[7]  W. Lennox BRAIN INJURY, DRUGS, AND ENVIRONMENT AS CAUSES OF MENTAL DECAY IN EPILEPSY , 1942 .

[8]  C. Dodrill,et al.  Cognitive and quality of life effects of differing dosages of tiagabine in epilepsy , 1997, Neurology.

[9]  K. Meador,et al.  Comparative cognitive effects of phenobarbital, phenytoin, and valproate in healthy adults , 1995, Neurology.

[10]  I. Fried,et al.  Long‐term follow‐up after temporal lobe resection for lesions associated with chronic seizures , 1997, Neurology.

[11]  O. Devinsky Cognitive and Behavioral Effects of Antiepileptic Drugs , 1995, Epilepsia.

[12]  J. Cramer,et al.  Quality of life for people with epilepsy. , 1994, Neurologic clinics.

[13]  K. Furusho,et al.  Genetic polymorphism of the CYP2C subfamily and its effect on the pharmacokinetics of phenytoin in Japanese patients with epilepsy , 1997, Clinical pharmacology and therapeutics.

[14]  S. D. Moore,et al.  Seizure-like activity disrupts LTP in vitro , 1993, Neuroscience Letters.

[15]  S. Shorvon,et al.  Reduction in polypharmacy for epilepsy. , 1979, British medical journal.

[16]  K. Meador,et al.  Review: Neuropsychological Effects of Antiepileptic Drugs A Current Perspective , 1993, Clinical neuropharmacology.

[17]  M. J. Brodie,et al.  Drug therapy : antiepileptic drugs , 1996 .

[18]  J. Hughlings Jackson,et al.  CASE OF EPILEPSY WITH TASTING MOVEMENTS AND “DREAMY STATE”—VERY SMALL PATCH OF SOFTENING IN THE LEFT UNCINATE GYRUS , 1898 .

[19]  M. Jokelainen,et al.  Motor and cognitive functions in newly diagnosed adult seizure patients before antiepileptic medication , 2000, Acta neurologica Scandinavica.

[20]  B. Bourgeois Antiepileptic Drugs, Learning, and Behavior in Childhood Epilepsy , 1998, Epilepsia.

[21]  K. Meador,et al.  Comparative cognitive effects of carbamazepine and phenytoin in healthy adults , 1991, Neurology.

[22]  M. Trimble Carbamazepine and mood: evidence from patients with seizure disorders. , 1988, The Journal of clinical psychiatry.

[23]  C. Elger,et al.  Right hippocampal contribution to visual memory: a presurgical and postsurgical study in patients with temporal lobe epilepsy , 1998, Journal of neurology, neurosurgery, and psychiatry.

[24]  C. Dodrill,et al.  Neuropsychological effects of carbamazepine and phenytoin , 1991, Neurology.

[25]  Simon Shorvon,et al.  Multicenter Double‐Blind, Randomized, Placebo‐Controlled Trial of Levetiracetam as Add‐On Therapy in Patients with Refractory Partial Seizures , 2000 .

[26]  M. Brodie,et al.  New antiepileptic drugs , 1996, The New England journal of medicine.

[27]  C. D. Binnie,et al.  Psychological effects of subclinical epileptiform EEG discharges in children. II. General intelligence tests , 1988, Epilepsy Research.

[28]  M. Trimble 11. Epilepsy and behaviour , 1991, Epilepsy Research.

[29]  F. Monaco Cognitive effects of vigabatrin , 1996, Neurology.

[30]  J. Cramer,et al.  Effect of valproate on cognitive functioning. Comparison with carbamazepine. The Department of Veterans Affairs Epilepsy Cooperative Study 264 Group. , 1996, Archives of neurology.

[31]  P. Kwan,et al.  Early identification of refractory epilepsy. , 2000, The New England journal of medicine.

[32]  J. Edinger,et al.  Reversible parkinsonism and cognitive impairment with chronic valproate use , 1996, Neurology.

[33]  A. Aldenkamp,et al.  Memory complaints in epilepsy: correlations with cognitive performance and neuroticism , 1993, Epilepsy Research.

[34]  M. Brodie,et al.  Cognitive effects of anticonvulsant monotherapy in elderly patients: a placebo-controlled study , 1998, Seizure.

[35]  G. Frommer,et al.  Mood Change Preceding Epileptic Seizures , 1986, The Journal of nervous and mental disease.

[36]  J. Engel,et al.  The timing of surgical intervention for mesial temporal lobe epilepsy: a plan for a randomized clinical trial. , 1999, Archives of neurology.

[37]  Colin D. Binnie,et al.  The influence of subclinical epileptiform EEG discharges on driving behaviour. , 1987 .

[38]  J. Fawcett Predictors of early suicide: identification and appropriate intervention. , 1988, The Journal of clinical psychiatry.

[39]  C. Binnie Significance and management of transitory cognitive impairment due to subclinical EEG discharges in children , 1993, Brain and Development.

[40]  M. Trimble,et al.  Effects of Removal of Phenytoin, Carbamazepine, and Valproate on Cognitive Function , 1990, Epilepsia.

[41]  A. Murro,et al.  Differential Cognitive Effects of Carbamazepine and Gabapentin , 1999, Epilepsia.

[42]  H. Jokeit,et al.  Long term effects of refractory temporal lobe epilepsy on cognitive abilities: a cross sectional study , 1999, Journal of neurology, neurosurgery, and psychiatry.

[43]  A. Aldenkamp,et al.  Phenytoin and carbamazepine: Differential effects on cognitive function , 1995, Seizure.

[44]  R. Bornstein,et al.  Effects of seizure type and waveform abnormality on memory and attention. , 1988, Archives of neurology.

[45]  J. Cramer,et al.  Effect of Levetiracetam on Epilepsy‐Related Quality of Life , 2000, Epilepsia.

[46]  T. Miyamoto,et al.  Psychotic episodes during Zonisamide treatment , 2000, Seizure.

[47]  R. Levin,et al.  Psychosocial Dimensions of Epilepsy: A Review of the Literature , 1988, Epilepsia.

[48]  M. Griebel,et al.  Does Short‐Term Antiepileptic Drug Treatment in Children Result in Cognitive or Behavioral Changes? , 1998, Epilepsia.

[49]  M. Brodie,et al.  Multicentre, double-blind, randomised comparison between lamotrigine and carbamazepine in elderly patients with newly diagnosed epilepsy , 1999, Epilepsy Research.

[50]  Mark S. Seidenberg,et al.  Neuropsychological characteristics of the syndrome of mesial temporal lobe epilepsy. , 1997, Archives of neurology.

[51]  D. Dinner,et al.  Mental Deterioration in Epilepsy , 1986, Epilepsia.

[52]  M. Brodie,et al.  Effect of vigabatrin on sedation and cognitive function in patients with refractory epilepsy. , 1993, Journal of neurology, neurosurgery, and psychiatry.

[53]  C. Polkey,et al.  Relationships between neuropathology and cognitive functioning in temporal lobectomy patients. , 1987, Journal of neurology, neurosurgery, and psychiatry.

[54]  M. Brodie,et al.  Gabapentin and cognition: a double blind, dose ranging, placebo controlled study in refractory epilepsy. , 1997, Journal of neurology, neurosurgery, and psychiatry.

[55]  E. Gibbs,et al.  Epilepsy: a paroxysmal cerebral dysrhythmia , 1937, Epilepsy & Behavior.

[56]  C. Dodrill,et al.  Psychotropic effects of carbamazepine in epilepsy , 1977, Neurology.

[57]  J. Cramer,et al.  Results of a Nationwide Veterans Administration Cooperative Study Comparing the Efficacy and Toxicity of Carbamazepine, Phenobarbital, Phenytoin, and Primidone , 1987, Epilepsia.

[58]  L. Provinciali,et al.  Influence of vigabatrin on cognitive performances and behaviour in patients with drug‐resistant epilepsy , 1996, Acta neurologica Scandinavica.

[59]  M. Brodie,et al.  Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy , 1995, The Lancet.

[60]  A. Aldenkamp Effect of Seizures and Epileptiform Discharges on Cognitive Function , 1997, Epilepsia.

[61]  J. Wagner,et al.  Zonisamide (CI‐912) and Cognition: Results from Preliminary Study , 1987, Epilepsia.

[62]  S. Shinnar,et al.  Long-term prognosis of seizures with onset in childhood. , 1998, The New England journal of medicine.

[63]  David F. Smith,et al.  Topiramate in clinical practice: first year’s postlicensing experience in a specialist epilepsy clinic , 1999, Journal of neurology, neurosurgery, and psychiatry.

[64]  J. Cramer,et al.  Behavioral Characteristics of Epilepsy Patients Compared with Normal Controls , 1986, Epilepsia.

[65]  G. Baker,et al.  The Stigma of Epilepsy: A European Perspective , 2000, Epilepsia.

[66]  Frederick Andermann,et al.  Neuroimaging evidence of progressive neuronal loss and dysfunction in temporal lobe epilepsy , 1999, Annals of neurology.

[67]  C. Dodrill Problems in the Assessment of Cognitive Effects of Antiepileptic Drugs , 1992, Epilepsia.

[68]  F. Dreifuss,et al.  Levetiracetam for partial seizures , 2000, Neurology.

[69]  M. Brodie,et al.  A double-blind, placebo-controlled interaction study between oxcarbazepine and carbamazepine, sodium valproate and phenytoin in epileptic patients. , 1994, British journal of clinical pharmacology.

[70]  R. Beran,et al.  Aggressive Behaviour in Intellectually Challenged Patients with Epilepsy Treated with Lamotrigine , 1998, Epilepsia.

[71]  L. Gjerstad,et al.  Cognitive Function and Time‐of‐Day Variation in Serum Carbamazepine Concentration in Epileptic Patients Treated with Monotherapy , 1991, Epilepsia.

[72]  D. Hirtz,et al.  Late Cognitive Effects of Early Treatment with Phenobarbital , 1999, Clinical pediatrics.

[73]  K. Meador Cognitive and behavioral assessments in AED trials. , 1998, Advances in neurology.

[74]  R. Appleton Treatment of childhood epilepsy. , 1995, Pharmacology & therapeutics.

[75]  T. Pedley,et al.  “The Scarlet E” , 2000, Neurology.

[76]  O. Devinsky,et al.  Behavioral changes associated with epilepsy. , 1993, Neurologic clinics.

[77]  M. Trimble Anticonvulsant Drugs and Cognitive Function: A Review of the Literature , 1987, Epilepsia.

[78]  G. Avanzini,et al.  Learning and Memory Impairment in Patients with Temporal Lobe Epilepsy: Relation to the Presence, Type, and Location of Brain Lesion , 1999, Epilepsia.

[79]  M. Brodie,et al.  Lamotrigine substitution study: evidence for synergism with sodium valproate? , 1997, Epilepsy Research.

[80]  K. Meador,et al.  Epilepsy, anticonvulsant drugs and cognition. , 1996, Bailliere's clinical neurology.

[81]  A. Ylinen,et al.  Long‐term efficacy and cognitive effects of vigabatrin , 1995, Acta neurologica Scandinavica. Supplementum.

[82]  C. D. Binnie,et al.  Psychological effects of subclinical epileptiform EEG discharges. I. Scholastic skills , 1988, Epilepsy Research.

[83]  M. Brodie,et al.  Topiramate in Refractory Epilepsy: A Prospective Observational Study , 2000, Epilepsia.

[84]  C. Dodrill,et al.  Effects of Tiagabine Monotherapy on Abilities, Adjustment, and Mood , 1998, Epilepsia.

[85]  A. Marson,et al.  Neuropsychological Outcomes in Randomized Controlled Trials of Antiepileptic Drugs: A Systematic Review of Methodology and Reporting Standards , 1998, Epilepsia.

[86]  G. Baker,et al.  Outcomes of Add‐on Treatment with Lamotrigine in Partial Epilepsy , 1993, Epilepsia.

[87]  G. Krauss,et al.  “The Scarlet E” , 2000, Neurology.

[88]  M. Brodie,et al.  Management of epilepsy in adolescents and adults , 2000, The Lancet.

[89]  K. Meador,et al.  Comparative cognitive effects of anticonvulsants , 1990, Neurology.

[90]  T. Sutula,et al.  Progression in mesial temporal lobe epilepsy , 1999, Annals of neurology.

[91]  M. Brodie,et al.  Monostars: An Aid to Choosing an Antiepileptic Drug as Monotherapy , 1999, Epilepsia.

[92]  M. Trimble,et al.  Anticonvulsant Drugs and Cognitive Functions , 1982, Epilepsia.

[93]  S. Moshé,et al.  Gabapentin Toxicity in Children Manifesting as Behavioral Changes , 1995, Epilepsia.

[94]  Josemir W Sander,et al.  Neuropsychological effects of tiagabine, a potential new antiepileptic drug , 1994, Seizure.

[95]  R. Tallis,et al.  Impact of Valproate and Phenytoin on Cognitive Function in Elderly Patients: Results of a Single‐Blind Randomized Comparative Study , 1994, Epilepsia.

[96]  C D Binnie,et al.  Selective cognitive impairment during focal and generalized epileptiform EEG activity. , 1984, Brain : a journal of neurology.

[97]  L F Quesney,et al.  Clinical and EEG Features of Complex Partial Seizures of Temporal Lobe Origin , 1986, Epilepsia.

[98]  C. Dodrill,et al.  Neuropsychological Abilities Before and After 5 Years of Stable Antiepileptic Drug Therapy , 1992, Epilepsia.

[99]  G. Gallup,et al.  A Survey of Public Attitudes Toward Epilepsy in 1974 With an Indication of Trends Over the Past Twenty‐Five Years , 1965, Epilepsia.

[100]  L. Provinciali,et al.  Recognition Impairment Correlated with Short Bisynchronous Epileptic Discharges , 1991, Epilepsia.

[101]  Jullie W Pan,et al.  Cognitive effects of topiramate, gabapentin, and lamotrigine in healthy young adults , 1999, Neurology.

[102]  Simon Ball,et al.  Pharmacogenetics and drug metabolism , 1997, Nature Biotechnology.

[103]  R. Kälviäinen,et al.  Cognitive Adverse Effects of Antiepileptic Drugs , 1996, CNS drugs.

[104]  M. Brodie,et al.  Cognitive function in adult epileptic patients established on anticonvulsant monotherapy , 1990, Epilepsy Research.

[105]  T. Halonen,et al.  Cognitive effects of oxcarbazepine and phenytoin monotherapy in newly diagnosed epilepsy: one year follow-up , 1992, Epilepsy Research.

[106]  E. Somerfeld-Ziskind,et al.  EFFECT OF PHENOBARBITAL ON THE MENTALITY OF EPILEPTIC PATIENTS , 1940 .

[107]  C. Dodrill Correlates of Generalized Tonic‐Clonic Seizures with Intellectual, Neuropsychological, Emotional, and Social Function in Patients with Epilepsy , 1986, Epilepsia.

[108]  M. Brodie,et al.  Rapid tolerance to acute psychomotor impairment with carbamazepine in epileptic patients. , 1992, British journal of clinical pharmacology.

[109]  M. Brodie Drug Interactions in Epilepsy , 1992, Epilepsia.

[110]  M. Brodie,et al.  Concentration-effect relationships with carbamazepine and its epoxide on psychomotor and cognitive function in epileptic patients. , 1988, Journal of neurology, neurosurgery, and psychiatry.

[111]  K. Meador Cognitive Side Effects of Antiepileptic Drugs , 1994, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[112]  L. Lamoreaux,et al.  Effect of gabapentin (neurotonin®) on mood and well-being in patients with epilepsy , 1996, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[113]  M. Falconer Reversibility by temporal-lobe resection of the behavioral abnormalities of temporal-lobe epilepsy. , 1973, The New England journal of medicine.

[114]  B. Levin,et al.  Cognitive outcome of children with epilepsy and malformations of cortical development , 2000, Neurology.

[115]  A. Cole,et al.  Early-life seizures in rats increase susceptibility to seizure-induced brain injury in adulthood , 1999, Neurology.

[116]  E. Vining Cognitive Dysfunction Associated with Antiepileptic Drug Therapy , 1987, Epilepsia.

[117]  C. Dodrill Neuropsychological aspects of epilepsy. , 1992, The Psychiatric clinics of North America.

[118]  M. Trimble,et al.  Effects of Vigabatrin on Cognitive Function and Mood When Used as Add‐on Therapy in Patients with Intractable Epilepsy , 1992, Epilepsia.

[119]  M. Jokelainen,et al.  Comparing the Cognitive Effects of Phenytoin and Carbamazepine in Long‐Term Monotherapy: A Two‐Year Follow‐Up , 1995, Epilepsia.

[120]  M. Brodie,et al.  Cognitive function in adult epileptic patients on long-term sodium valproate , 1991 .

[121]  E. Beghi,et al.  Adverse Reactions to Antiepileptic Drugs: A Multicenter Survey of Clinical Practice , 1986 .

[122]  A. Kanner,et al.  Positive and Negative Psychotropic Effects of Lamotrigine in Patients with Epilepsy and Mental Retardation , 1998, Epilepsia.

[123]  A. Roses,et al.  Pharmacogenetics and future drug development and delivery , 2000, The Lancet.

[124]  H. Meinardi,et al.  Reappraisal of Polytherapy in Epilepsy: A Critical Review of Drug Load and Adverse Effects , 1997, Epilepsia.

[125]  M. Relling,et al.  Pharmacogenomics: translating functional genomics into rational therapeutics. , 1999, Science.

[126]  R. Kuzniecky,et al.  Acute psychotic symptoms induced by topiramate , 1999, Seizure.

[127]  G. Mawer,et al.  Respiratory and sedative effects of clobazam and clonazepam in volunteers. , 1990, British journal of clinical pharmacology.

[128]  I. Gamstorp,et al.  A Double‐blind Study of Clonazepam in the Treatment of Therapy‐resistant Epilepsy in Children , 1977, Developmental medicine and child neurology.

[129]  M. Brodie,et al.  New antiepileptic drugs. , 1996, The New England journal of medicine.

[130]  M. Brodie,et al.  Epilepsy in elderly people , 2005, British medical journal.

[131]  P. Crandall,et al.  Special report. The nature of aggression during epileptic seizures. , 1981, The New England journal of medicine.

[132]  K. Meador,et al.  The relationship between memory performance, perceived cognitive function, and mood in patients with epilepsy , 1999, Epilepsy Research.

[133]  A. Aldenkamp,et al.  Cognitive side-effects of chronic antiepileptic drug treatment: A review of 25 years of research , 1995, Epilepsy Research.

[134]  Theresa M. Voorhies Cognitive and Behavioral Effects of Antiepileptic Drugs , 1988, Seminars in neurology.

[135]  P. Crawford An audit of topiramate use in a general neurology clinic , 1998, Seizure.

[136]  T. S. Kerson,et al.  The Depiction of Seizures in Film , 1999, Epilepsia.

[137]  M. Nahata,et al.  Gabapentin Associated with Aggressive Behavior in Pediatric Patients with Seizures , 1996, Epilepsia.

[138]  P. Riekkinen,et al.  Long-term cognitive and EEG effects of tiagabine in drug-resistant partial epilepsy , 1996, Epilepsy Research.

[139]  M. Trimble,et al.  Effects of gabapentin on cognition and quality of life in patients with epilepsy , 1998, Seizure.